Biogen Inc (BIIB)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 2,156,300 2,168,700 1,580,700 1,576,200 1,543,300 1,838,900 3,346,900 3,931,900 3,926,300 4,144,500 3,083,300 1,838,600 1,862,200 1,411,700 2,040,700 3,999,100 5,215,400 6,550,000 7,354,400 7,090,100
Long-term debt US$ in thousands 4,547,200 6,788,200 6,567,300 7,567,300 7,500,000
Total stockholders’ equity US$ in thousands 16,716,000 16,358,900 15,889,100 15,213,000 14,799,400 14,483,800 14,466,900 13,796,600 13,397,900 12,775,500 11,872,500 11,242,300 10,896,200 10,429,900 10,751,900 10,682,200 10,700,300 10,758,500 11,308,700 12,546,900
Return on total capital 10.14% 13.26% 9.95% 10.36% 7.15% 12.70% 23.13% 28.50% 19.67% 32.44% 25.97% 16.35% 10.09% 13.54% 18.98% 37.44% 28.66% 60.88% 65.03% 56.51%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $2,156,300K ÷ ($4,547,200K + $16,716,000K)
= 10.14%

Biogen Inc's return on total capital fluctuated over the period from March 31, 2020, to December 31, 2024. The return on total capital was relatively high in the second quarter of 2020 at 65.03% and decreased to 18.98% by the second quarter of 2021. There was a gradual increase in the return on total capital from March 31, 2021, to September 30, 2022, reaching 32.44%. However, the return on total capital declined in the following quarters, reaching a low of 7.15% by December 31, 2023. The return on total capital slightly improved in the subsequent quarters, ending at 10.14% by December 31, 2024. The fluctuations in the return on total capital indicate changes in the company's efficiency in generating profits from its total capital employed during the period under consideration.